CLINICAL_TRIALS
trial_result
· 2022-09-22
Clinical Trial Update: An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma [Phase 2]
Summary
Phase 2 trial update evaluating amatuximab (MORAb-009) for malignant pleural mesothelioma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphotek | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-22